USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancer. TNBC does not express the estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2. Cytotoxic chemotherapy and surgery are the current therapeutic strategies for TNBC patients, but the chemore...
Main Authors: | Yueh-Te Lin, Joseph Lin, Yi-En Liu, Yun-Cen Chen, Shiang-Ting Liu, Kai-Wen Hsu, Dar-Ren Chen, Han-Tsang Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/20/3294 |
Similar Items
-
Deciphering the functional role of clinical mutations in ABCB1, ABCC1, and ABCG2 ABC transporters in endometrial cancer
by: Aayushi Gupta, et al.
Published: (2024-05-01) -
Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma
by: Zigui Chen, et al.
Published: (2023-09-01) -
The 26S Proteasome Switches between ATP-Dependent and -Independent Mechanisms in Response to Substrate Ubiquitination
by: Abramo J. Manfredonia, et al.
Published: (2022-05-01) -
Ubiquitin-specific proteases (USPs) in leukemia: a systematic review
by: Alireza Zangooie, et al.
Published: (2024-07-01) -
The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
by: Zhang Dian, et al.
Published: (2024-08-01)